Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies
Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 2010; 28: 1062-1068.
Safety of influenza A (H1N1) 2009 monovalent vaccines-United States, October 1-November 24, 2009
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention (CDC). Safety of influenza A (H1N1) 2009 monovalent vaccines-United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 1351-1356.
Ministry of Health of the People's Republic of China, (Accessed March 19, 2010 at)
Ministry of Health of the People's Republic of China. Report of vaccination of H1N1 influenza Book Report of vaccination of H1N1 influenza. (Accessed March 19, 2010 at http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohjbyfkzj/s3578/201003/46348.htm.)
Chinese Center for Disease Control and Prevention (Chinese CDC), (Accessed 2010 at)
Chinese Center for Disease Control and Prevention (Chinese CDC). Answers for recent questions of vaccination of H1N1 influenza in China. (Accessed 2010 at http://www.chinacdc. net.cn/n272442/n272530/n3226631/36054.html.)
Hepatitis B vaccine and uveitis: An emerging hypothesis suggested by review of 32 case reports
Fraunfelder FW, Suhler EB, Fraunfelder FT. Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol 2010; 29: 26-29.